Gene therapy for coronary artery disease: preclinical and initial clinical results with intracoronary administration of Ad5FGF-4.
Watkins
M W
MW
University of Vermont College of Medicine, Cardiology Unit, McClure 1, 111 Colchester Avenue, Burlington, VT 05401, USA. matthew.watkins@vtmednet.org
Rubanyi
G M
GM
D000818:Animals; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D051519:Fibroblast Growth Factor 4; D005346:Fibroblast Growth Factors / Q000235:genetics* / Q000627:therapeutic use*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000627:therapeutic use*; D013552:Swine; D013997:Time Factors
C496445:FGF4 protein, human; D051519:Fibroblast Growth Factor 4; D011518:Proto-Oncogene Proteins; D005346:Fibroblast Growth Factors